Different quacks than the ones who say everyone MUST get a vaccine no matter what.
Covid Vaccine
- Thread starter jitter77
- Start date
- Joined
- Apr 21, 2014
- Messages
- 5,840
- Reaction score
- 4,788
- Points
- 113
Oh absolutely. Trump was just the catalyst that sent their mental illness into overdrive. Anyone who was strongly Pro America and who didn't allow the media to lie and bully everyone into submission would have gotten the same reaction. He is a threat to them because freedom is a threat to them.
Because they get paid to do it.
I'm not a medical doctor but you're still an idiot.
I read one, it was a hospital or school can’t remember. They had a form, so if you did medical your doc would have to sign off on it. I swear religion had something similar where your priest or whatever had to as well.
Last edited:
Your own President has spoken: "While cases are on the rise, we’re not likely to see according to the experts a comparable rise in hospitalizations or deaths."
Clearly you disagree with Joe then. We are not in a dangerous place. Just like India wasn't, like the UK wasn't. The massive death is over. No matter how much you wish for it to continue. You're going to need to find a new hobby.
Says the person who would willingly vaccinate all of our youth, a dangerous thing to do. Says the tool who would gleefully root for more lockdowns, which have killed untold tens of thousands, with numbers rising. You persistently refuse to look at the effects of the lockdowns, because only some lives matter. We care about all lives...those that could be lost to COVID and those that are lost due to the draconian measures we have taken. You? You don't. You could give a **** if a family loses their income, if dad hangs himself, if businesses are shuttered, if people don't get their healthcare and die from cancer. Those lives simply don't matter to you.
You are the death cult. And we are fighting it.
Says the tool who dismisses all data and facts and now stands in opposition to his own President.
Says the tool who anointed Michael Avenatti an American Patriot and Hero, called India a RAGING INFERNO, and persistently spreads misinformation on this site that is proven false over and over and over and over again.
AAAAnnnndddd once again, Floggy using a sample outlier utterly rare instance to paint a broad brush.
We see hundreds of thousands of people getting COVID again that are on the vax.
We've learned this week breakthrough infections are not only not rare, but apparently utterly common.
Provide some data on reinfections among the naturally immune. We will wait.
Damn. Damn facts.
Recovered COVID-19 patients retain broad and effective longer-term immunity to the disease, suggests a recent Emory University study, which is the most comprehensive of its kind so far. The findings have implications for expanding understanding about human immune memory as well as future vaccine development for coronaviruses.
The longitudinal study, published recently on Cell Reports Medicine, looked at 254 patients with mostly mild to moderate symptoms of SARS-CoV-2 infection over a period for more than eight months (250 days) and found that their immune response to the virus remained durable and strong.
Emory Vaccine Center director Rafi Ahmed, PhD, and a lead author on the paper, says the findings are reassuring, especially given early reports during the pandemic that protective neutralizing antibodies did not last in COVID-19 patients.
“The study serves as a framework to define and predict long-lived immunity to SARS-CoV-2 after natural infection. We also saw indications in this phase that natural immunity could continue to persist,” Ahmed says. The research team will continue to evaluate this cohort over the next few years.
Researchers found that not only did the immune response increase with disease severity, but also with each decade of age regardless of disease severity, suggesting that there are additional unknown factors influencing age-related differences in COVID-19 responses.
In following the patients for months, researchers got a more nuanced view of how the immune system responds to COVID-19 infection. The picture that emerges indicates that the body’s defense shield not only produces an array of neutralizing antibodies but activates certain T and B cells to establish immune memory, offering more sustained defenses against reinfection.
“We saw that antibody responses, especially IgG antibodies, were not only durable in the vast majority of patients but decayed at a slower rate than previously estimated, which suggests that patients are generating longer-lived plasma cells that can neutralize the SARS-CoV-2 spike protein.”
Ahmed says investigators were surprised to see that convalescent participants also displayed increased immunity against common human coronaviruses as well as SARS-CoV-1, a close relative of the current coronavirus. The study suggests that patients who survived COVID-19 are likely to also possess protective immunity even against some SARS-CoV-2 variants.
“Vaccines that target other parts of the virus rather than just the spike protein may be more helpful in containing infection as SARS-CoV-2 variants overtake the prevailing strains,” says Ahmed. “This could pave the way for us to design vaccines that address multiple coronaviruses.”
Researchers say the study more comprehensively identifies the adaptive immune components leading to recovery, and that it will serve as a benchmark for immune memory induced by SARS-CoV-2 vaccines. “We can build on these results to define the progression to long-lived immunity against the new coronavirus, which can guide rational responses when future outbreaks occur,” says Ahmed.
The study, funded by multiple institutions including the National Institutes of Health, is a collaboration between Emory University and the Fred Hutchinson Cancer Research Center in Seattle, Washington.
COVID-19 survivors may possess wide-ranging resistance to the disease
Recovered COVID-19 patients retain broad and effective longer-term immunity to the disease, suggests a recent Emory University study, which is the most comprehensive of its kind so far. The findings have implications for expanding understanding about human immune memory as well as future vaccine...
news.emory.edu
Recovered COVID-19 patients retain broad and effective longer-term immunity to the disease, suggests a recent Emory University study, which is the most comprehensive of its kind so far. The findings have implications for expanding understanding about human immune memory as well as future vaccine development for coronaviruses.
The longitudinal study, published recently on Cell Reports Medicine, looked at 254 patients with mostly mild to moderate symptoms of SARS-CoV-2 infection over a period for more than eight months (250 days) and found that their immune response to the virus remained durable and strong.
Emory Vaccine Center director Rafi Ahmed, PhD, and a lead author on the paper, says the findings are reassuring, especially given early reports during the pandemic that protective neutralizing antibodies did not last in COVID-19 patients.
“The study serves as a framework to define and predict long-lived immunity to SARS-CoV-2 after natural infection. We also saw indications in this phase that natural immunity could continue to persist,” Ahmed says. The research team will continue to evaluate this cohort over the next few years.
Researchers found that not only did the immune response increase with disease severity, but also with each decade of age regardless of disease severity, suggesting that there are additional unknown factors influencing age-related differences in COVID-19 responses.
In following the patients for months, researchers got a more nuanced view of how the immune system responds to COVID-19 infection. The picture that emerges indicates that the body’s defense shield not only produces an array of neutralizing antibodies but activates certain T and B cells to establish immune memory, offering more sustained defenses against reinfection.
“We saw that antibody responses, especially IgG antibodies, were not only durable in the vast majority of patients but decayed at a slower rate than previously estimated, which suggests that patients are generating longer-lived plasma cells that can neutralize the SARS-CoV-2 spike protein.”
Ahmed says investigators were surprised to see that convalescent participants also displayed increased immunity against common human coronaviruses as well as SARS-CoV-1, a close relative of the current coronavirus. The study suggests that patients who survived COVID-19 are likely to also possess protective immunity even against some SARS-CoV-2 variants.
“Vaccines that target other parts of the virus rather than just the spike protein may be more helpful in containing infection as SARS-CoV-2 variants overtake the prevailing strains,” says Ahmed. “This could pave the way for us to design vaccines that address multiple coronaviruses.”
Researchers say the study more comprehensively identifies the adaptive immune components leading to recovery, and that it will serve as a benchmark for immune memory induced by SARS-CoV-2 vaccines. “We can build on these results to define the progression to long-lived immunity against the new coronavirus, which can guide rational responses when future outbreaks occur,” says Ahmed.
The study, funded by multiple institutions including the National Institutes of Health, is a collaboration between Emory University and the Fred Hutchinson Cancer Research Center in Seattle, Washington.
- Joined
- Apr 9, 2014
- Messages
- 4,586
- Reaction score
- 9,201
- Points
- 113
Title 28
Chapter 23
28 Pa. Code § 23.84. Exemption from immunization.
Read the cross sections mentioned below. My son is 20 and was able to gain approval from the college, and the Dean mentioned that PA has laws in place to allow adults to deny the immunization for religeous reasons. Now, the business or School could make you wear a mask and stick you in a quarantine cubic or some dumb ****. But then, there is fair and equal treatment laws that could be put forth to stop that **** too.
I’m ******* super man now!!!!! Let’s ******* gooooo!!! **** your pokeDamn. Damn facts.
COVID-19 survivors may possess wide-ranging resistance to the disease
Recovered COVID-19 patients retain broad and effective longer-term immunity to the disease, suggests a recent Emory University study, which is the most comprehensive of its kind so far. The findings have implications for expanding understanding about human immune memory as well as future vaccine...news.emory.edu
View attachment 5903
Recovered COVID-19 patients retain broad and effective longer-term immunity to the disease, suggests a recent Emory University study, which is the most comprehensive of its kind so far. The findings have implications for expanding understanding about human immune memory as well as future vaccine development for coronaviruses.
The longitudinal study, published recently on Cell Reports Medicine, looked at 254 patients with mostly mild to moderate symptoms of SARS-CoV-2 infection over a period for more than eight months (250 days) and found that their immune response to the virus remained durable and strong.
Emory Vaccine Center director Rafi Ahmed, PhD, and a lead author on the paper, says the findings are reassuring, especially given early reports during the pandemic that protective neutralizing antibodies did not last in COVID-19 patients.
“The study serves as a framework to define and predict long-lived immunity to SARS-CoV-2 after natural infection. We also saw indications in this phase that natural immunity could continue to persist,” Ahmed says. The research team will continue to evaluate this cohort over the next few years.
Researchers found that not only did the immune response increase with disease severity, but also with each decade of age regardless of disease severity, suggesting that there are additional unknown factors influencing age-related differences in COVID-19 responses.
In following the patients for months, researchers got a more nuanced view of how the immune system responds to COVID-19 infection. The picture that emerges indicates that the body’s defense shield not only produces an array of neutralizing antibodies but activates certain T and B cells to establish immune memory, offering more sustained defenses against reinfection.
“We saw that antibody responses, especially IgG antibodies, were not only durable in the vast majority of patients but decayed at a slower rate than previously estimated, which suggests that patients are generating longer-lived plasma cells that can neutralize the SARS-CoV-2 spike protein.”
Ahmed says investigators were surprised to see that convalescent participants also displayed increased immunity against common human coronaviruses as well as SARS-CoV-1, a close relative of the current coronavirus. The study suggests that patients who survived COVID-19 are likely to also possess protective immunity even against some SARS-CoV-2 variants.
“Vaccines that target other parts of the virus rather than just the spike protein may be more helpful in containing infection as SARS-CoV-2 variants overtake the prevailing strains,” says Ahmed. “This could pave the way for us to design vaccines that address multiple coronaviruses.”
Researchers say the study more comprehensively identifies the adaptive immune components leading to recovery, and that it will serve as a benchmark for immune memory induced by SARS-CoV-2 vaccines. “We can build on these results to define the progression to long-lived immunity against the new coronavirus, which can guide rational responses when future outbreaks occur,” says Ahmed.
The study, funded by multiple institutions including the National Institutes of Health, is a collaboration between Emory University and the Fred Hutchinson Cancer Research Center in Seattle, Washington.
Wow. And watch the Jimmy Dore clip.
citizenfreepress.com
It happened. Just tested positive for COVID.
Spent all pandemic being cautious:
Got swabbed often.
Got 2 doses of the Pfizer vaccine as soon as I had the chance.
Continued to mask afterwards.
Wore PPE with each patient encounter.
And it STILL happened. I am so fckng tired.
— Ayla B., MD (@DrAylaSays) August 1, 2021
Dr. Ayla had a breakdown on Twitter yesterday. The cognitive dissonance is stunning.
So Dore has long lasting (they haven't left) reactions to the jab, and for telling his reaction to it, he is shamed.
The guy still to this day suffers joint pain and fevers and still has brain swelling........
Scary what is happening in this world. Really.
Braindead Doctor catches Covid after living like a psycho hermit lady for 18 months…
Dr. Ayla had a breakdown on Twitter yesterday. The cognitive dissonance is stunning. Perhaps she should have listened to Jimmy Dore… &n…
citizenfreepress.com
It happened. Just tested positive for COVID.
Spent all pandemic being cautious:
Got swabbed often.
Got 2 doses of the Pfizer vaccine as soon as I had the chance.
Continued to mask afterwards.
Wore PPE with each patient encounter.
And it STILL happened. I am so fckng tired.
— Ayla B., MD (@DrAylaSays) August 1, 2021
Dr. Ayla had a breakdown on Twitter yesterday. The cognitive dissonance is stunning.
So Dore has long lasting (they haven't left) reactions to the jab, and for telling his reaction to it, he is shamed.
The guy still to this day suffers joint pain and fevers and still has brain swelling........
Scary what is happening in this world. Really.
It is appearing, the longer this goes on....if you have COVID...you are most protected.
- Joined
- Sep 12, 2014
- Messages
- 15,783
- Reaction score
- 6,253
- Points
- 113
For **** sake, Tim. The only support for your bat **** crazy anti-vac ideology is “sample outlier (much more) utterly rare instances” of severe side effects.
If 160 million have had Covid, isnt reinfection self evident with this latest surge? Or is Lamar Jackson the only one?
- Joined
- Sep 12, 2014
- Messages
- 15,783
- Reaction score
- 6,253
- Points
- 113
Young People Are Biggest Group of Newly Hospitalized COVID-19 Patients
The most recent CDC data shows COVID-19-related hospitalizations are again increasing, with the age group most affected being ages 18 to 49.
www.healthline.com
Hospitals In Southern U.S. Report Record Numbers Of Children Hospitalized Amid Delta Surge—Though Deaths Still Extremely Rare
Hospitals in multiple southern states are reporting a sharp uptick in the number of children they are seeing admitted, with some hitting new pandemic records.
www.forbes.com
- Joined
- Sep 12, 2014
- Messages
- 15,783
- Reaction score
- 6,253
- Points
- 113
When using “may”, it’s not a fact, Tim.Damn. Damn facts.
COVID-19 survivors may possess wide-ranging resistance to the disease
Recovered COVID-19 patients retain broad and effective longer-term immunity to the disease, suggests a recent Emory University study, which is the most comprehensive of its kind so far. The findings have implications for expanding understanding about human immune memory as well as future vaccine...news.emory.edu
View attachment 5903
Recovered COVID-19 patients retain broad and effective longer-term immunity to the disease, suggests a recent Emory University study, which is the most comprehensive of its kind so far. The findings have implications for expanding understanding about human immune memory as well as future vaccine development for coronaviruses.
The longitudinal study, published recently on Cell Reports Medicine, looked at 254 patients with mostly mild to moderate symptoms of SARS-CoV-2 infection over a period for more than eight months (250 days) and found that their immune response to the virus remained durable and strong.
Emory Vaccine Center director Rafi Ahmed, PhD, and a lead author on the paper, says the findings are reassuring, especially given early reports during the pandemic that protective neutralizing antibodies did not last in COVID-19 patients.
“The study serves as a framework to define and predict long-lived immunity to SARS-CoV-2 after natural infection. We also saw indications in this phase that natural immunity could continue to persist,” Ahmed says. The research team will continue to evaluate this cohort over the next few years.
Researchers found that not only did the immune response increase with disease severity, but also with each decade of age regardless of disease severity, suggesting that there are additional unknown factors influencing age-related differences in COVID-19 responses.
In following the patients for months, researchers got a more nuanced view of how the immune system responds to COVID-19 infection. The picture that emerges indicates that the body’s defense shield not only produces an array of neutralizing antibodies but activates certain T and B cells to establish immune memory, offering more sustained defenses against reinfection.
“We saw that antibody responses, especially IgG antibodies, were not only durable in the vast majority of patients but decayed at a slower rate than previously estimated, which suggests that patients are generating longer-lived plasma cells that can neutralize the SARS-CoV-2 spike protein.”
Ahmed says investigators were surprised to see that convalescent participants also displayed increased immunity against common human coronaviruses as well as SARS-CoV-1, a close relative of the current coronavirus. The study suggests that patients who survived COVID-19 are likely to also possess protective immunity even against some SARS-CoV-2 variants.
“Vaccines that target other parts of the virus rather than just the spike protein may be more helpful in containing infection as SARS-CoV-2 variants overtake the prevailing strains,” says Ahmed. “This could pave the way for us to design vaccines that address multiple coronaviruses.”
Researchers say the study more comprehensively identifies the adaptive immune components leading to recovery, and that it will serve as a benchmark for immune memory induced by SARS-CoV-2 vaccines. “We can build on these results to define the progression to long-lived immunity against the new coronavirus, which can guide rational responses when future outbreaks occur,” says Ahmed.
The study, funded by multiple institutions including the National Institutes of Health, is a collaboration between Emory University and the Fred Hutchinson Cancer Research Center in Seattle, Washington.
is that why the ************ addressed this in his State of the Union speech? the very ******* speech that Nancy Pelosi tore up then danced a jig in Chinatown? I can't remember, but YouTube be do that memory for you.
- Joined
- Apr 8, 2014
- Messages
- 8,252
- Reaction score
- 8,040
- Points
- 113
Do you have a study or any data that shows unvaccinated people with previous infections are getting reinfected (or hospitalized or dying) at greater rates than those who are just vaccinated? Anything?
- Joined
- Apr 9, 2014
- Messages
- 4,586
- Reaction score
- 9,201
- Points
- 113
I'm floored that these libtards can make a statement, get smacked with facts right across the forehead, and then simply move on to their next gaffe like nothing ever happened. You would think that at some point they would begin to question their understanding of the subject and perhaps, even the foundation of their logic.
But no, they move onto the next lie or poorly made Meme shrouded in continued ignorance. SMH
Reinfection is appearing, in the data we have, to be among the vaccinated. 75% of those in MA were vaccinated. 40% of those infected in Israel were vaccinated. Hundreds of thousands of infections in the US were vaccinated people according to Reuters.
News stories about the naturally infected? Pretty ******* rare.
You read those tea leaves any way you want. I'm not seeing any articles about 10s, hundreds or thousands of naturally immune reinfected, are you?
Butttttttttt Lamar Jackson...LOL
Yer better off having had COVID than having the jab <---------that's becoming pretty clear so far.
READ the article **** stick. Read about the study and the facts.
WE ALL KNOW YOU ARE ALLERGIC TO FACTS and we know it ******* pains you to no end to know that the naturally immune are kicking *** right now. Which also makes you one sick **** besides being the board's biggest dumbass. You make 21 look like a mensa at times.
-------------------
From the article:
Recovered COVID-19 patients retain broad and effective longer-term immunity to the disease, suggests a recent Emory University study, which is the most comprehensive of its kind so far. The findings have implications for expanding understanding about human immune memory as well as future vaccine development for coronaviruses.
The longitudinal study, published recently on Cell Reports Medicine, looked at 254 patients with mostly mild to moderate symptoms of SARS-CoV-2 infection over a period for more than eight months (250 days) and found that their immune response to the virus remained durable and strong.
-------------------
Read the study - https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(21)00203-2
Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of >200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ memory B cells persist, which bodes well for a rapid antibody response upon virus re-exposure or vaccination. Virus-specific CD4+ and CD8+ T cells are polyfunctional and maintained with an estimated half-life of 200 days. Interestingly, CD4+ T cell responses equally target several SARS-CoV-2 proteins, whereas the CD8+ T cell responses preferentially target the nucleoprotein, highlighting the potential importance of including the nucleoprotein in future vaccines. Taken together, these results suggest that broad and effective immunity may persist long-term in recovered COVID-19 patients.
-------------------
After 8 months, patients have durable immune system responses - i.e., they still have natural immunity.
After 8 months, patients exhibit signs of longer-lived plasma cells.
After 8 months, patients have boosted antibody titers to multiple coronaviruses.
After 8 months, patients have memory B cells.
That's better protection than a vax. They keep studying these patients. First it was after 3 months, robust defenses found in the patients. Remember others were predicting natural immunity would wear off. Now they do a study for 8 months, and patients still have a robust defense.
What will you do **** stick, when studies show natural immunity still going strong after 14 months? Say that it "may" not last for life then too?
Sorry your beloved vaccines have developed a bit of a re-infection hole. I mean, a gaping, massive holy-**** size whole with reinfections.
But why do you hate people that are naturally beating the virus? Do you want people to die?
They're like Charlie and Algernon, only they never had the neurosurgery.
- Joined
- Apr 9, 2014
- Messages
- 4,586
- Reaction score
- 9,201
- Points
- 113
Devil's advocate: So why is the FDA telling people not to get the antibody tests? Why do you need a prescription to go have one done? Why is the antibody test almost $43 when people are getting paid to take the vaccine? Why are Covid tests free but the antibody test's aren't? Why is the focus on a vaccine and not on how we are building up our defenses naturally?
Could it be that if more people were tested, herd immunity would be realized on a greater scale than most people think and the vaccine would be far less significant in saving the population?